A PYMNTS Company

J&J gets approval to buy Synthes, as EC accepts its commitment to sell trauma business

 |  April 19, 2012

The European Commission has approved Johnson & Johnson’s proposed acquisition of Synthes, subject to J&J selling their trauma business. Johnson & Johnson had submitted commitments to selling their European trauma device business, given the Commission’s findings of J&J and Synthes’ market shares and the reluctance of surgeons in switching suppliers.

Following an investigation into the market for orthopedic medical devices, the Commission found that strong competitors for spine, shoulder replacement and cranio-maxillofacial devices would remain after the transaction.

Full content: EC Press Release


Related contentAnalyzing Medical Device Mergers


Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.